Genomics Market: By Product Type, By Technology, By Application, By End User and Region Forecast 2019-2030  

Genomics Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product Type (Reagents and Kits, Instruments, Software and Services), By Technology (Next Generation Sequencing, Polymerase Chain Reaction, Nucleic Acid Extraction and Purification, Microarray, Others), By Application (Diagnostics, Drug Discovery and Development, Precision/Personalized Medicine, Others), By End User (Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, Academic and Government Institutes, Clinical Research, Others) and Region Forecast 2019-2030  

Genomics Market size was valued at US$ 28,736.5 million in 2023 and is projected to reach US$ 63,131.3 million by 2030, growing at a CAGR of 11.9% from 2024-2030. Market growth is by technology, disease prevalence, influx of investments, and the field of personalized medicine.

Growth is also restricted by high costs, private issues, a complicated regulatory environment, and talent shortages. More opportunities include personalized medicine, bioinformatics, rare disease research, and pharmaceuticals due to direct-to-consumer testing, the usage of AI, collaborations, and population genomics. Government support such as in the case of the U.S. NIH's $3.8 billion funding in genomics in 2022 underscores its strategic importance for health care. Yet, further attention to the well-trodden path of ethical, regulatory, and data security concerns will be critical in fully unlocking the potential of the market while overcoming public trust and access barriers.

Key Players

The Genomics Market size includes several companies such as Illumina, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Agilent Technologies, Inc, Oxford Nanopore Technologies, Danaher, QIAGEN, BGI, IntegraGen, General Electric Company, and among others.

Key Takeaways

  • Reagents and kits hold the highest market share in this category. This is because of the critical functions that reagents and kits perform in genome testing and research.
  • Technology-wise, the market is dominated by Next Generation Sequencing. With the ability to make high-throughput, accurate, and cost-effective sequencing of DNA, NGS holds significant relevance to genomics research, clinical diagnostics, and personalized medicine.
  • Diagnostics has the highest market share in application due to the high demand for genomic testing in disease diagnostics, such as famous cancer genomics, prenatal testing, and infectious diseases, which fuels the trend; therefore, genomic tools enable precise diagnostic advice.
  • The pharmaceutical and biotechnology firms represent the largest share of the end-users, due to the high investment involved in drug discovery, development, and personalized medicine.

Facts and Figure

  • The Chinese government reportedly invested nearly $10 billion in the genomic sector in the last ten years.
  • In Asia-Pacific healthcare spending in the region is also rising strongly to reach $3.5 trillion by 2025.
  • China initiated the China Precision Medicine Initiative in 2015 which commits an investment of $9.2 billion for 15 years in researching the genome and health.
  • National Institutes of Health (NIH) budgeted $3.8 billion in 2022 for genomics, aiming to advance research and treatment.
  • In 2019, the EU committed €600 million to the "1+ Million Genomes" project, which will interlink genomic data across member states by 2025. This cross-country project would help in the use of genomics-based healthcare and research throughout Europe.
  • In 2020, £200 million was allocated to Genomics England to expand sequencing efforts into rare diseases and cancer genomics, further entrenching the country in genomics research.
  • The UK government has heavily invested in genomics through initiatives like Genomics England and the 100,000 Genomes Project. The latter, completed in 2018, provided critical data to support personalized treatment approaches.
  • In India, the government has recently allocated $1 billion towards genomics-based research under the Biotechnology Industry Research Assistance Council (BIRAC).

Key Developments

  • In Jan 2024, QIAGEN Digital Insights announced the latest version of its software application for QIAGEN CLC Genomics Workbench Premium with LightSpeed technology, which supports somatic cancer secondary analysis using next-generation sequencing. This accelerator for software transforms raw sequencing data from FASTQ files into easily readable lists of genetic variants in VCF files at unprecedented low cost and at unprecedented speeds.
  • In March 2023, Illumina, Inc. launched an advanced cloud-based solution called Connected Insights designed to support tertiary analysis of clinical next-generation sequencing data. The software will enable genomic profiling for more advanced tumors, and whole-genome sequencing for rare diseases and other applications.
  • In February 2023, Thermo Fisher Scientific, Inc. released a new PCR test called TrueMark STI Select Panel, detecting Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium for research use only.
  • In February 2023, Eppendorf AG (Germany) expanded its Chinese production site by commissioning a new production facility in Shanghai.  
  • In October 2022, Oxford Nanopore Technologies partnered with US-based 10x Genomics in order to assist scientists in streamlined workflows to allow for the direct sequencing of full-length transcripts from a single read using accessibly available, highly sensitive Oxford Nanopore devices.

Genomics Market Segmentation

By Product Type: Reagents and kits hold the highest market share in this category. This is because of the critical functions that reagents and kits perform in genome testing and research. These commodities are used in genomic practices such as NGS and PCR. With the increasing use of genomic technologies in diagnosis and drug discovery, so does the demand for quality reagents and kits.

By Technology: Technology-wise, the market is dominated by Next Generation Sequencing. With the ability to make high-throughput, accurate, and cost-effective sequencing of DNA, NGS holds significant relevance to genomics research, clinical diagnostics, and personalized medicine. Acceptance of NGS in both clinical and research environments and its capacity to generate large-scale genomic data guarantee NGS market leadership.

By Application: In the application segment, diagnostics has the highest market share. High demand for genomic testing in disease diagnostics, such as famous cancer genomics, prenatal testing, and infectious diseases, fuels the trend; therefore, genomic tools enable precise diagnostic advice, which forms the majority of this growth in diagnostics that is required for individualized treatment plans.

By End User: The pharmaceutical and biotechnology firms represent the largest share of the final users. Because of the high investment involved in the application of genomics in drug discovery, development, and personalized medicine, these companies are engaging heavily in it. NGS technologies, among others, are used widely to identify genetic variations that explain diseases, thus leading to the development of targeted therapies. Biotechnology companies are applying genomics for genomic research and innovations.

Genomics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

11.9%

Largest Market

North America

Fastest Growing Market

Asia Pacific

Genomics Market Dynamics

Drivers

The genomics market enjoys rapid technological advances in the form of next-generation sequencing and CRISPR, which enables genomic analysis at faster speeds and lower costs. This makes it more inviting to research and clinical adopters in much greater scale. Growing rates of chronic diseases, such as cancer and diabetes, also make more demand, since genomics helps to design personalized treatment plans for patients to achieve better health outcomes. Strong government and private investments also add to the growth in the market; for instance, in 2022, the U.S. NIH committed $3.8 billion to genomics research for accelerated healthcare development. Additionally, the exploding domain of precision medicine which provides customized healthcare solutions is strictly dependent on genomics for the optimized treatments and this, therefore, offers an enormous motivation toward continuous investments.

Restraints

Despite the growth, the genomics market still lags. Its price is still a deterrent since many lands in the region are at lower income levels, and most people still cannot afford any services of advanced genomics. Moreover, issues on data privacy and security have prompted them not to use sensitive genetic information since misuse is feared. Also, the regulatory environment varies from country to country, hence incongruent across countries and, therefore, a deterrent to further growth and progress in research. Apart from this, the unavailability of skilfully trained professionals-bioinformaticians and geneticists-strains productivity and innovation, pushing the time to the point when these genomic insights are translated into clinical solutions. These constraints speak to a need for industry-wide responses focused on sustainable growth and wider access to genomics.

Opportunities

Growth opportunities exist in genomics, particularly in personalized medicine, where genetic insights allow for tailored treatments to better enhance patient care. The sheer volume of genomic data also creates a sectoral opportunity for bioinformatics, because new tools are needed to interpret the increasingly complex data sets that are being generated as a resultant area of technological innovation. Genomics also offers exciting routes forward for rare diseases, where the infrequent occurrence of the disease inherently represents an unmet need, and new investment in novel therapies is encouraged. These further benefit the pharmaceutical industry as genomics helps identify genetic markers involved with disease; this would improve drug discovery and development, enhance the effectiveness and specificity of new treatments, and catalyze industry advances.

Trends

The genomics market is shaped by a few trends, such as Direct-to-consumer (DTC) testing, led by companies like 23andMe, which has brought genetic information within the reach of many more people, hence fueling the growth of the market. Artificial intelligence and machine learning speed up and improve the accuracy of data analysis in genomics and form the basis for precision medicine. Other recent trends that increased the portfolio of resources for progress in research and innovations are the growing collaboration between the academic, biotechnology, and healthcare sectors. For instance, the UK Biobank population genomics initiative postulates that large-scale data collection on genetics might improve the understanding of public health, therefore creating massive resources for future studies. This trend suggests an ever-changing landscape of enormous potential for further development.

Genomics Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 28,736.5 million

Market Size in 2030

US$ 63,131.3 million

Market CAGR

11.9%

By Product Type

  • Reagents and Kits
  • Instruments
  • Software
  • Services

By Technology

  • Next Generation Sequencing
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Microarray
  • Others

By Application

  • Drug Discovery and Development
  • Diagnostics
  • Agriculture and Animal Research
  • Others

By End Users

  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Clinics
  • Academic and Government Institutes
  • Clinical Research
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Analyst Review

The genomics market is now on a tectonic shift with driving forces in terms of improvement in sequencing technology, expanding applications in personalized medicine, and huge government and private investments. North America holds the top position due to intensive R&D funding, the well-developed healthcare infrastructure, and major genomics firms. Asia-Pacific also indicates marvelous growth potential, supported by large-scale genomic projects, where government is the backbone, and with growing demand for precision medicine. However, analysts also face challenges such as privacy concerns concerning data, regulatory complexity, and the requirement for technical expertise that need to be addressed to fully exploit the health-related and research-related potential of genomics.

 

Key Features of the Report

  • The genomics market report provides granular level information about the market size, regional market share, historic market and forecast
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startups details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porters Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

The global genomics market size was valued US$ 28,736.5 million in 2023 set to reach at US$ 63,131.3 million by 2030, at a CAGR of 11.9% from 2024-2030.

• Technological Advancements
• Rising Prevalence of Chronic Diseases
• Government and Private Investments
• Precision Medicine Growth

• High Costs
• Data Privacy Concerns
• Complex Regulatory Landscape
• Skill Shortages

• Integration of AI and Machine Learning in Genomics
• Increased Focus on Genetic Screening
• Rise of CRISPR and Gene Editing Technologies
• Growing Demand for Genomic Data Storage Solutions

Illumina, Inc., Thermo Fisher Scientific, QIAGEN N.V, Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Eurofins Scientific, MGI Tech Co., Ltd, MERCK KGAA, PROMEGA CORPORATION, and among others are the key players in the genomics market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1. Executive Summary
2. Global Genomics Market Introduction
2.1. Global Genomics Market - Taxonomy
2.2. Global Genomics Market -Definitions
2.2.1. By Product Type
2.2.2. By Technology
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3. Global Genomics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Genomics Market Dynamic Factors - Impact Analysis
3.6. Global Genomics Market - Competition Landscape
4. Global Genomics Market Analysis, 2019 - 2023 and Forecast, 2024-2030
4.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Genomics Market, By Product Type, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
5.1. Reagents and Kits
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. Instruments
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Software and Services
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
6. Global Genomics Market, By Technology, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
6.1. Next Generation Sequencing
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Polymerase Chain Reaction
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Nucleic Acid Extraction and Purification
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Microarray
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Others
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
7. Global Genomics Market, By Application, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
7.1. Diagnostics
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Drug Discovery and Development
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Precision/Personalized Medicine
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
8. Global Genomics Market, By End User, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. Hospitals and Clinics
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic and Government Institutes
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
8.4. Clinical Research
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.4.3. Market Opportunity Analysis
8.5. Others
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.5.3. Market Opportunity Analysis
9. Global Genomics Market Forecast, By Region, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
9.1. North America
9.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Region, 2024-2030
10. North America Genomics Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
10.1. Product Type Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Reagents and Kits
10.1.2. Instruments
10.1.3. Software and Services
10.2. Technology Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Next Generation Sequencing
10.2.2. Polymerase Chain Reaction
10.2.3. Nucleic Acid Extraction and Purification
10.2.4. Microarray
10.2.5. Others
10.3. Application Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Diagnostics
10.3.2. Drug Discovery and Development
10.3.3. Precision/Personalized Medicine
10.3.4. Others
10.4. End User Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. Hospitals and Clinics
10.4.3. Academic and Government Institutes
10.4.4. Clinical Research
10.4.5. Others
10.5. Country Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2024-2030
10.7. North America Genomics Market Dynamics - Trends
11. Europe Genomics Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
11.1. Product Type Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Reagents and Kits
11.1.2. Instruments
11.1.3. Software and Services
11.2. Technology Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Next Generation Sequencing
11.2.2. Polymerase Chain Reaction
11.2.3. Nucleic Acid Extraction and Purification
11.2.4. Microarray
11.2.5. Others
11.3. Application Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Diagnostics
11.3.2. Drug Discovery and Development
11.3.3. Precision/Personalized Medicine
11.3.4. Others
11.4. End User Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. Hospitals and Clinics
11.4.3. Academic and Government Institutes
11.4.4. Clinical Research
11.4.5. Others
11.5. Country Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2024-2030
11.7. Europe Genomics Market Dynamics - Trends
12. Asia-Pacific Genomics Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
12.1. Product Type Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Reagents and Kits
12.1.2. Instruments
12.1.3. Software and Services
12.2. Technology Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Next Generation Sequencing
12.2.2. Polymerase Chain Reaction
12.2.3. Nucleic Acid Extraction and Purification
12.2.4. Microarray
12.2.5. Others
12.3. Application Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Diagnostics
12.3.2. Drug Discovery and Development
12.3.3. Precision/Personalized Medicine
12.3.4. Others
12.4. End User Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. Hospitals and Clinics
12.4.3. Academic and Government Institutes
12.4.4. Clinical Research
12.4.5. Others
12.5. Country Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2024-2030
12.7. Asia-Pacific Genomics Market Dynamics - Trends
13. Latin America Genomics Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
13.1. Product Type Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Reagents and Kits
13.1.2. Instruments
13.1.3. Software and Services
13.2. Technology Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Next Generation Sequencing
13.2.2. Polymerase Chain Reaction
13.2.3. Nucleic Acid Extraction and Purification
13.2.4. Microarray
13.2.5. Others
13.3. Application Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Diagnostics
13.3.2. Drug Discovery and Development
13.3.3. Precision/Personalized Medicine
13.3.4. Others
13.4. End User Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. Hospitals and Clinics
13.4.3. Academic and Government Institutes
13.4.4. Clinical Research
13.4.5. Others
13.5. Country Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2024-2030
13.7. Latin America Genomics Market Dynamics - Trends
14. Middle East and Africa Genomics Market Analysis, 2019 - 2023 and Forecast, 2024-2030 (Revenue, US$ Mn)
14.1. Product Type Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Reagents and Kits
14.1.2. Instruments
14.1.3. Software and Services
14.2. Technology Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Next Generation Sequencing
14.2.2. Polymerase Chain Reaction
14.2.3. Nucleic Acid Extraction and Purification
14.2.4. Microarray
14.2.5. Others
14.3. Application Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Diagnostics
14.3.2. Drug Discovery and Development
14.3.3. Precision/Personalized Medicine
14.3.4. Others
14.4. End User Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. Hospitals and Clinics
14.4.3. Academic and Government Institutes
14.4.4. Clinical Research
14.4.5. Others
14.5. Country Analysis 2019 - 2023 and Forecast 2024-2030 by Revenue (US$ Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Genomics Market - Opportunity Analysis Index, By Product Type, Technology, Application, End User, and Country, 2024-2030
14.7. MEA Genomics Market Dynamics - Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Illumina, Inc.
15.2.2. Thermo Fisher Scientific
15.2.3. QIAGEN N.V.
15.2.4. Agilent Technologies, Inc.
15.2.5. F. Hoffmann-La Roche Ltd.
15.2.6. Bio-Rad Laboratories, Inc.
15.2.7. Eurofins Scientific
15.2.8. 10x Genomics
15.2.9. 23andMe, Inc.
15.2.10. PROMEGA CORPORATION
16. Research Methodology
17. Key Assumptions and Acronyms

 

Key Market Players

  • Illumina, Inc.
  • Thermo Fisher Scientific
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Bio-Rad Laboratories, Inc.
  • Eurofins Scientific
  • MGI Tech Co., Ltd.
  • MERCK KGAA
  • PROMEGA CORPORATION
  • 10x Genomics
  • 23andMe, Inc

Related Industry Reports